On What Science Says podcast, our goal is to bring your attention to actionable items that are scientifically proven to improve your health and wellbeing. Together, we will discuss existing and emerging science about how our body works and how we can cooperate with it, with evidence-based methods from world experts and peer-reviewed publications. Mahshad Kolahdouzan, our host, is a neuroscience PhD candidate at the University of Toronto and The Hospital for Sick Children. She has extensive knowledge on the effects of nutrition on the brain and how chronic pain develops.
All content for What Science Says is the property of Mahshad Kolahdouzan and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
On What Science Says podcast, our goal is to bring your attention to actionable items that are scientifically proven to improve your health and wellbeing. Together, we will discuss existing and emerging science about how our body works and how we can cooperate with it, with evidence-based methods from world experts and peer-reviewed publications. Mahshad Kolahdouzan, our host, is a neuroscience PhD candidate at the University of Toronto and The Hospital for Sick Children. She has extensive knowledge on the effects of nutrition on the brain and how chronic pain develops.
5. Can Omega-3 Protect Against Alzheimer's Disease?
What Science Says
5 minutes 46 seconds
2 years ago
5. Can Omega-3 Protect Against Alzheimer's Disease?
In this episode of the WhatScienceSays podcast, we learn about the protective effects of omega-3 against Alzheimer's disease. We learn about the dosage and the specific type of omega-3 fatty acid that is most beneficial. This episode is hosted by Mahshad, a neuroscientist and PhD candidate at the University of Toronto and The Hospital for Sick Children.
References:
1. Chiu CC, Su KP, Cheng TC, Liu HC, Chang CJ, Dewey ME, Stewart R, Huang SY. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(6):1538-44.
2. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006 Oct;63(10):1402-8.
3. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, Blackwell A, Salem N Jr, Stedman M; MIDAS Investigators. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64.
4. Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21.
5. Cunnane SC, Plourde M, Pifferi F, Bégin M, Féart C, Barberger-Gateau P. Fish, docosahexaenoic acid and Alzheimer's disease. Prog Lipid Res. 2009 Jan;48(1):239-56.
What Science Says
On What Science Says podcast, our goal is to bring your attention to actionable items that are scientifically proven to improve your health and wellbeing. Together, we will discuss existing and emerging science about how our body works and how we can cooperate with it, with evidence-based methods from world experts and peer-reviewed publications. Mahshad Kolahdouzan, our host, is a neuroscience PhD candidate at the University of Toronto and The Hospital for Sick Children. She has extensive knowledge on the effects of nutrition on the brain and how chronic pain develops.
